Beneficial associations of low and large doses of leisure time physical activity with all-cause, cardiovascular disease and cancer mortality: a national cohort study of 88,140 US adults
original abstract †Abstracts here may not perfectly match originals, for a variety of technical and practical reasons. Some abstacts are truncated for my purposes here, if they are particularly long-winded and unhelpful. I occasionally add clarifying notes. And I make some minor corrections.
Background Evidence on the role of very low or very high volumes of leisure time physical activity (PA) on the risk of all-cause and cause-specific mortality is limited. We aimed to examine the associations of different levels of leisure time PA with the risk of all-cause, cardiovascular disease (CVD) and cancer-specific mortality.Methods Data were from 12 waves of the National Health Interview Surveys (1997{\textendash}2008) linked to the National Death Index records through 31 December 2011. A total of 88 140 eligible participants aged 40{\textendash}85 years were included.Results Compared with inactive individuals, those performing 10{\textendash}59 min/week of PA had 18\% lower risk of all-cause mortality (hazard ratio (HR): 0.82, 95\% confidence interval (CI): 0.72{\textendash}0.95). Those who reported 1{\textendash}2 times (150{\textendash}299 min/week) the recommended level of leisure time PA had 31\% (HR: 0.69, 95\%CI: 0.63{\textendash}0.75) reduced risk of all-cause mortality. Importantly, the continued benefits were observed among those performing leisure time PA 10 or more times (>=1500 min/week) the recommended minimum level (HR: 0.54, 95\% CI: 0.45{\textendash}0.64). For 10{\textendash}59, 150{\textendash}299 and >=1500 min/week of PA, the corresponding HRs (95\% CIs) for CVD-specific mortality were 0.88 (0.67{\textendash}1.17), 0.63 (0.52{\textendash}0.78) and 0.67 (0.45{\textendash}0.99), respectively: for cancer-specific mortality were 0.86 (0.66{\textendash}1.11), 0.76 (0.64{\textendash}0.89) and 0.53 (0.39{\textendash}0.73), respectively. In addition, there was a larger reduction in all-cause and cause-specific mortality for vigorous vs. moderate intensity PA.Conclusions We found that beneficial association between leisure time PA and mortality starts from a low dose. Doing more vigorous exercise could lead to additional health benefits.
related content
- “Exercise: The miracle cure and the role of the doctor in promoting it,” Academy of Medical Royal Colleges, AOMRC.org.uk, 2015.
- Exercise is Power: Resistance Training for Older Adults on YouTube.com.
- “Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases,” Pedersen et al, Scandinavian Journal of Medicine & Science in Sports, 2015.
- “Physical activity protects from incident anxiety: A meta-analysis of prospective cohort studies,” Schuch et al, Depress Anxiety, 2019.
- “Semantic memory functional MRI and cognitive function after exercise intervention in mild cognitive impairment,” Smith et al, J Alzheimers Dis, 2013.
Specifically regarding Zhao 2019:
This page is part of the PainScience BIBLIOGRAPHY, which contains plain language summaries of thousands of scientific papers & others sources. It’s like a highly specialized blog. A few highlights:
- Topical glyceryl trinitrate (GTN) and eccentric exercises in the treatment of mid-portion achilles tendinopathy (the NEAT trial): a randomised double-blind placebo-controlled trial. Kirwan 2024 Br J Sports Med.
- Placebo analgesia in physical and psychological interventions: Systematic review and meta-analysis of three-armed trials. Hohenschurz-Schmidt 2024 Eur J Pain.
- Recovery trajectories in common musculoskeletal complaints by diagnosis contra prognostic phenotypes. Aasdahl 2021 BMC Musculoskelet Disord.
- Cannabidiol (CBD) products for pain: ineffective, expensive, and with potential harms. Moore 2023 J Pain.
- Moderators of the effect of therapeutic exercise for knee and hip osteoarthritis: a systematic review and individual participant data meta-analysis. Holden 2023 The Lancet Rheumatology.